title: Methylation and silencing of miRNA-124 by EVI1 and self-renewal exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome.
abstract: By expressing EVI1 in murine bone marrow (BM), we previously described a myelodysplastic syndrome (MDS) model characterized by pancytopenia, dysmegakaryopoiesis, dyserythropoiesis, and BM failure. The mice invariably died 11-14 months after BM transplantation (BMT). Here, we show that a double point mutant EVI1-(1+6Mut), unable to bind Gata1, abrogates the onset of MDS in the mouse and re-establishes normal megakaryopoiesis, erythropoiesis, BM function, and peripheral blood profiles. These normal features were maintained in the reconstituted mice until the study was ended at 21 months after BMT. We also report that EVI1 deregulates several genes that control cell division and cell self-renewal. In striking contrast, these genes are normalized in the presence of the EVI1 mutant. Moreover, EVI1, but not the EVI1 mutant, seemingly deregulates these cellular processes by altering miRNA expression. In particular, the silencing of miRNA-124 by DNA methylation is associated with EVI1 expression, but not that of the EVI1 mutant, and appears to play a key role in the up-regulation of cell division in murine BM cells and in the hematopoietic cell line 32Dcl3. The results presented here demonstrate that EVI1 induces MDS in the mouse through two major pathways, both of which require the interaction of EVI1 with other factors: one, results from EVI1-Gata1 interaction, which deregulates erythropoiesis and leads to fatal anemia, whereas the other occurs by interaction of EVI1 with unidentified factors causing perturbation of the cell cycle and self-renewal, as a consequence of silencing miRNA-124 by EVI1 and, ultimately, ensues in BM failure.
authors.affiliation: Department of Pathology, University of Chicago, Chicago, IL 60637, USA. Jerome.Dickstein@uchospitals.edu
authors.forename: Jerome
authors.initials: J
authors.lastname: Dickstein
authors.forename: Vitalyi
authors.initials: V
authors.lastname: Senyuk
authors.forename: Kavitha
authors.initials: K
authors.lastname: Premanand
authors.forename: Leopoldo
authors.initials: L
authors.lastname: Laricchia-Robbio
authors.forename: Peng
authors.initials: P
authors.lastname: Xu
authors.forename: Francesca
authors.initials: F
authors.lastname: Cattaneo
authors.forename: Raffaella
authors.initials: R
authors.lastname: Fazzina
authors.forename: Giuseppina
authors.initials: G
authors.lastname: Nucifora
mesh_terms: D000818:Animals; D016026:Bone Marrow Transplantation; D002454:Cell Differentiation; D049109:Cell Proliferation; D002478:Cells, Cultured; D018899:CpG Islands; D004261:DNA Replication; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D005786:Gene Expression Regulation; D006412:Hematopoietic Stem Cells / Q000166:cytology*; D000074008:MDS1 and EVI1 Complex Locus Protein; D008745:Methylation; D051379:Mice; D035683:MicroRNAs / Q000235:genetics*; D008969:Molecular Sequence Data; D009154:Mutation; D009190:Myelodysplastic Syndromes / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology; D011401:Promoter Regions, Genetic; D011519:Proto-Oncogenes / Q000235:genetics; D034622:RNA Interference; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism*
chemical_list: D004268:DNA-Binding Proteins; D000074008:MDS1 and EVI1 Complex Locus Protein; C499305:Mecom protein, mouse; D035683:MicroRNAs; C540079:Mirn124 microRNA, mouse; D014157:Transcription Factors
references.citation: Cell Growth Differ. 1999 Sep;10(9):601-10
references.pmid: 10511310
references.citation: Science. 2005 May 20;308(5725):1171-4
references.pmid: 15905401
references.citation: Mol Cell Biol. 1992 Jan;12(1):183-9
references.pmid: 1370341
references.citation: Nat Med. 2010 Feb;16(2):198-204
references.pmid: 20098431
references.citation: EMBO J. 2004 Oct 13;23(20):4116-25
references.pmid: 15385956
references.citation: N Engl J Med. 1999 May 27;340(21):1649-60
references.pmid: 10341278
references.citation: Nat Genet. 2008 Jul;40(7):915-20
references.pmid: 18536716
references.citation: Carcinogenesis. 2010 May;31(5):766-76
references.pmid: 19843643
references.citation: Mech Dev. 1997 Jul;65(1-2):55-70
references.pmid: 9256345
references.citation: Blood. 2008 May 15;111(10):4841-51
references.pmid: 18467609
references.citation: Mol Cell Biol. 2006 Oct;26(20):7658-66
references.pmid: 16954386
references.citation: Cancer Cell. 2007 Oct;12(4):295-7
references.pmid: 17936553
references.citation: J Clin Invest. 2004 Sep;114(5):713-9
references.pmid: 15343390
references.citation: Ann N Y Acad Sci. 2005 Jun;1044:109-16
references.pmid: 15958703
references.citation: Nat Med. 2006 Apr;12(4):401-9
references.pmid: 16582916
references.citation: Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11857-62
references.pmid: 18697930
references.citation: BMC Med. 2008 Jun 24;6:14
references.pmid: 18577219
references.citation: Oncogene. 2002 May 13;21(21):3368-76
references.pmid: 12032775
references.citation: Blood. 2005 Oct 1;106(7):2530-3
references.pmid: 15933056
references.citation: Nature. 2003 May 15;423(6937):255-60
references.pmid: 12714970
references.citation: Blood Cells Mol Dis. 2008 Mar-Apr;40(2):141-7
references.pmid: 17913523
references.citation: Nature. 1994 Sep 15;371(6494):221-6
references.pmid: 8078582